Fine Mark National Bank & Trust Harrow Health, Inc. Transaction History
Fine Mark National Bank & Trust
- $2.84 Billion
- Q3 2024
A detailed history of Fine Mark National Bank & Trust transactions in Harrow Health, Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 22,730 shares of HROW stock, worth $833,509. This represents 0.04% of its overall portfolio holdings.
Number of Shares
22,730
Previous 22,730
-0.0%
Holding current value
$833,509
Previous $474,000
115.4%
% of portfolio
0.04%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$146 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$79.3 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$78.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$68.5 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$26.8 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $993M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...